APA (7th ed.) Citation

Goldinger, S. M., Schulz, C., & Hassel, J. C. (2014). Upstream mitogen-activated protein kinase (MAPK)pathway inhibition: MEK inhibitor followed by a BRAF inhibitor in advanced melanoma patients. European journal of cancer, 50(2), . https://doi.org/10.1016/j.ejca.2013.09.014

Chicago Style (17th ed.) Citation

Goldinger, Simone M., Carsten Schulz, and Jessica C. Hassel. "Upstream Mitogen-activated Protein Kinase (MAPK)pathway Inhibition: MEK Inhibitor Followed by a BRAF Inhibitor in Advanced Melanoma Patients." European Journal of Cancer 50, no. 2 (2014). https://doi.org/10.1016/j.ejca.2013.09.014.

MLA (9th ed.) Citation

Goldinger, Simone M., et al. "Upstream Mitogen-activated Protein Kinase (MAPK)pathway Inhibition: MEK Inhibitor Followed by a BRAF Inhibitor in Advanced Melanoma Patients." European Journal of Cancer, vol. 50, no. 2, 2014, https://doi.org/10.1016/j.ejca.2013.09.014.